Literature DB >> 14625080

Cloning, developmental regulation and neural localization of rat epsilon-sarcoglycan.

Jianfeng Xiao1, Mark S LeDoux.   

Abstract

Mutations in the gene for epsilon sarcoglycan (epsilon-SG) are associated with a disorder of the central nervous system, the myoclonus-dystonia syndrome (MDS; DYT11). In contrast, mutations of other sarcoglycan family members lead to limb-girdle muscular dystrophies. To establish the framework for functional studies of epsilon-SG, we cloned rat epsilon-SG cDNA, quantified epsilon-SG mRNA levels in neural and non-neural tissues at different developmental time points with relative quantitative multiplex real-time reverse transcriptase PCR (RT-PCR), and characterized the distribution of epsilon-SG mRNA in brain with in situ hybridization. Rat epsilon-SG cDNA contains an open reading frame (ORF) of 1311 bp that encodes a 437-amino acid (aa) protein with 95.9% and 98.2% identity to human and mouse epsilon-SG amino acid sequences, respectively. Using real-time RT-PCR, epsilon-SG was detected in both neural (cerebellar cortex, striatum, cerebral cortex, thalamus, hippocampus) and non-neural (muscle, liver, kidney, heart) tissues at each developmental time point tested [Embryonic Day 20 (E20), Postnatal Day 1 (P1), P7, P14, P36, 6 months, 1.5 years). Levels of epsilon-SG mRNA were highest at E20 in all tissues. The developmental regulation of epsilon-SG mRNA expression was most striking in muscle with E20 and early postnatal epsilon-SG mRNA levels over 10 times higher than those seen in adult rats. In adult rats, epsilon-SG mRNA levels were several-fold higher in brain, particularly cerebellar cortex, than in muscle. Radioactive in situ hybridization showed that epsilon-SG mRNA was widely distributed in rat brain. Robust hybridization signal was obtained from regions with dense neuronal packing such as the hippocampus, cerebellar molecular layer, and cerebral cortex. Our results suggest that epsilon-SG participates in the development of both neural and non-neural tissues and contributes to neuronal structure in the adult central nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625080     DOI: 10.1016/j.molbrainres.2003.09.004

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  12 in total

Review 1.  Primary dystonia: molecules and mechanisms.

Authors:  Lauren M Tanabe; Connie E Kim; Noga Alagem; William T Dauer
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

2.  Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce.

Authors:  Fumiaki Yokoi; Guang Yang; Jindong Li; Mark P DeAndrade; Tong Zhou; Yuqing Li
Journal:  J Biochem       Date:  2010-07-13       Impact factor: 3.387

3.  The sarcoglycan-sarcospan complex localization in mouse retina is independent from dystrophins.

Authors:  Patrice Fort; Francisco-Javier Estrada; Agnès Bordais; Dominique Mornet; José-Alain Sahel; Serge Picaud; Haydeé Rosas Vargas; Ramón M Coral-Vázquez; Alvaro Rendon
Journal:  Neurosci Res       Date:  2005-09       Impact factor: 3.304

4.  Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Guang Yang; Jindong Li; Atbin Doroodchi; Tong Zhou; Yuqing Li
Journal:  Behav Brain Res       Date:  2011-10-21       Impact factor: 3.332

5.  Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Tong Zhou; Yuqing Li
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

6.  Metabolic changes in DYT11 myoclonus-dystonia.

Authors:  Maren Carbon; Deborah Raymond; Laurie Ozelius; Rachel Saunders-Pullman; Steven Frucht; Vijay Dhawan; Susan Bressman; David Eidelberg
Journal:  Neurology       Date:  2013-01-02       Impact factor: 9.910

Review 7.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

8.  Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Francesca A Carlisle; Adrian J Waite; Derek J Blake; Ioannis Dragatsis; Yu Zhao; Mark S LeDoux
Journal:  Neurobiol Dis       Date:  2016-11-24       Impact factor: 5.996

Review 9.  ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.

Authors:  Ana Cazurro-Gutiérrez; Anna Marcé-Grau; Marta Correa-Vela; Ainara Salazar; María I Vanegas; Alfons Macaya; Àlex Bayés; Belén Pérez-Dueñas
Journal:  Mol Neurobiol       Date:  2021-04-22       Impact factor: 5.590

10.  Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.

Authors:  Lin Zhang; Fumiaki Yokoi; Dee S Parsons; David G Standaert; Yuqing Li
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.